CDKN2B and ischemic stroke: For example, DNA methylation of Cyclin-dependent kinase inhibitor 2B (CDKN2B) has been showcased to promote an increased risk of arterial calcification in ischemic stroke patients (Zhou et al., 2016; Zhou S. et al., 2017).